将重点从药物基因组学转向治疗诊断学。
Shifting emphasis from pharmacogenomics to theragnostics.
作者信息
Ozdemir Vural, Williams-Jones Bryn, Glatt Stephen J, Tsuang Ming T, Lohr James B, Reist Christopher
机构信息
Biomarker and Clinical Pharmacology Unit, VA Long Beach Healthcare System, Southern California Institute for Research and Education, University of California, Irvine, CA, USA.
出版信息
Nat Biotechnol. 2006 Aug;24(8):942-6. doi: 10.1038/nbt0806-942.
Abstract
What will be the role of theragnostic patents in upstream and downstream biomarker research?
摘要
诊疗一体化专利在上游和下游生物标志物研究中将发挥什么作用？
Zotero 插件